This article is more than 5 years old. Information may no longer be current.

Novartis announces new division heads of Alcon, Sandoz

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Jeff George will succeed Kevin Buehler as Division Head of Alcon, effective May 1, according to a press release from Novartis.

Buehler is retiring from the company and will provide management and strategic support on the Alcon business as part of the planned transition, the release said.

Richard Francis, after 13 years at Biogen Idec, will replace George as Division Head of Sandoz.

“The appointments of Jeff George as the new Division Head of Alcon and of Richard Francis as new Division Head of Sandoz place two strong leaders at the helm of two leading Novartis businesses. These new leaders will set the direction for the next phase of growth for our eye care and generics businesses, two of our core growth engines,” Joseph Jimenez, CEO of Novartis, said in the release.